Subjects: DOENÇAS DEGENERATIVAS (IMUNOLOGIA), IMUNOTERAPIA
ABNT
ESCALEIRA, M. T. F. et al. Measurement of antigenic PBMC response of multiple sclerossis patients recognizing synthetic MBP peptides: association with HLA-DR and clinical parameters. 2003, Anais.. Mangaratiba: Faculdade de Medicina, Universidade de São Paulo, 2003. . Acesso em: 10 out. 2024.APA
Escaleira, M. T. F., Guilherme, L., Oruê, I., Aliotti, S. P., Iwai, L., Kalil, J., et al. (2003). Measurement of antigenic PBMC response of multiple sclerossis patients recognizing synthetic MBP peptides: association with HLA-DR and clinical parameters. In . Mangaratiba: Faculdade de Medicina, Universidade de São Paulo.NLM
Escaleira MTF, Guilherme L, Oruê I, Aliotti SP, Iwai L, Kalil J, Callegaro D, Marchiori PE, Cunha Neto E. Measurement of antigenic PBMC response of multiple sclerossis patients recognizing synthetic MBP peptides: association with HLA-DR and clinical parameters. 2003 ;[citado 2024 out. 10 ]Vancouver
Escaleira MTF, Guilherme L, Oruê I, Aliotti SP, Iwai L, Kalil J, Callegaro D, Marchiori PE, Cunha Neto E. Measurement of antigenic PBMC response of multiple sclerossis patients recognizing synthetic MBP peptides: association with HLA-DR and clinical parameters. 2003 ;[citado 2024 out. 10 ]